Patheon, Inc. is a leading provider of outsourced pharmaceutical development and finished dosage manufacturing services to pharmaceutical and biotechnology companies. The Company has a fully integrated service offering, ranging from analytical development and pre-formulation to commercial manufacturing. Patheon operates manufacturing facilities located in the U.S., Canada, Italy, France and the U.K., manufacturing more than 750 products for over 250 clients. Patheon is a public company listed on the Toronto Stock Exchange under the symbol PTI.

© Copyright 2012 JLL Partners